American Rebel to Exit Nasdaq, Pivot to OTC Markets Amid Listing Challenges
Event summary
- American Rebel Holdings will not appeal Nasdaq’s delisting determination, effective February 13, 2026.
- The company will transition to OTC Markets, initially seeking quotation on OTCID with plans to upgrade to OTCQB.
- Nasdaq delisting stems from failure to maintain a $1.00 minimum bid price for 30 consecutive days.
- American Rebel reported $7.2M revenue and a $28.4M net loss for the nine months ended September 30, 2025.
- The company aims to relist on a national exchange after strengthening fundamentals and expanding operations.
The big picture
American Rebel’s exit from Nasdaq reflects broader challenges faced by small-cap companies navigating stringent listing standards and market volatility. The pivot to OTC Markets underscores a strategic shift to prioritize operational execution and capital access over short-term market visibility. The company’s long-term goal of relisting on a national exchange hinges on its ability to strengthen fundamentals and expand its brand footprint.
What we're watching
- Relisting Viability
- Whether American Rebel can execute its growth strategy and meet eligibility requirements for a national exchange relisting.
- OTC Market Dynamics
- How the transition to OTC Markets will impact liquidity, trading volume, and investor access.
- Financial Stability
- The pace at which the company can improve its financial health amid high debt and operating losses.
Related topics